← Back to Search

Shared Decision Aid for Myocardial Infarction

N/A
Waitlist Available
Led By John Dodson, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up visit 1 (day 0)
Awards & highlights

Study Summary

This trial will test a decision aid tool to help older patients with non-ST elevation myocardial infarction (NSTEMI) who are considering left heart catheterization (LHC) as treatment. The study will have two arms, with the first arm being the control group that will receive standard of care, while the second arm will have access to the decision aid and shared-decision making conversation with one of the co-investigators.

Eligible Conditions
  • NSTEMI (Non ST Segment Elevation Myocardial Infarction)

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~visit 1 (day 0)
This trial's timeline: 3 weeks for screening, Varies for treatment, and visit 1 (day 0) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percent change in mean decisional conflict score between the control and interventional group
Secondary outcome measures
Descriptive Statistics in the use of the Patient Decision Aid

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Shared decision aidExperimental Treatment1 Intervention
Patients in the interventional arm of the study will discuss catheterization with their treating physicians, in addition to having access to the shared decision aid tool and a shared decision conversation with a co-investigator clinician.
Group II: Standard of careActive Control1 Intervention
Patients in the control arm of the study will undergo standard of care treatment, discussing catheterization with their treating physicians.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Shared Decision Aid
2020
N/A
~20

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,368 Previous Clinical Trials
839,712 Total Patients Enrolled
13 Trials studying Myocardial Infarction
3,628 Patients Enrolled for Myocardial Infarction
John Dodson, MDPrincipal InvestigatorNYU Langone Health
3 Previous Clinical Trials
427 Total Patients Enrolled
1 Trials studying Myocardial Infarction
27 Patients Enrolled for Myocardial Infarction

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any current openings in this research project?

"Clinicaltrials.gov indicates that this clinical trial, which debuted on July 1st 2020 and was most recently modified on August 4th 2022, is not seeking participants at present; however, 30 other trials are running simultaneously and still taking in patients."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
A Pilot Proof of Concept, Randomized Controlled, Single-Center Study of a Decision Aid Tool for Older Patients Considering LHC as Treatment for NSTEMI
2020. "A Pilot Proof of Concept, Randomized Controlled, Single-Center Study of a Decision Aid Tool for Older Patients Considering LHC as Treatment for NSTEMI". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04270630.
~3 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top